A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
2017 · British Journal of Cancer · 60 citations
https://doi.org/10.1038/bjc.2017.109
A
Armando Orlandi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
221
Papers
2.5K
Citations
24
h-index
53
i10-index
Armando Orlandi is an academic researcher from Università Cattolica del Sacro Cuore. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology. The author has an h-index of 24, co-authored 188 publications.
ORCID: 0000-0001-5253-4678Papers by this author
worksTrastuzumab-induced corneal ulceration: successful no-drug treatment of a “blind” side effect in a case report
2015 · BMC Cancer · 38 citations
https://doi.org/10.1186/s12885-015-1969-3
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience
2018 · Journal of Cellular Physiology · 26 citations
https://doi.org/10.1002/jcp.27832
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases
2020 · Scientific Reports · 18 citations
https://doi.org/10.1038/s41598-020-67676-1
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial
2021 · The Lancet Regional Health - Western Pacific · 14 citations
https://doi.org/10.1016/j.lanwpc.2021.100158
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis
2023 · EClinicalMedicine · 8 citations
https://doi.org/10.1016/j.eclinm.2023.101824
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat